Polycyclic aromatic hydrocarbon metabolizing cytochrome P450s in freshly prepared uncultured rat blood lymphocytes

Biochemical Pharmacology

Volumn 79, Issue 8, 2010, Pages 1182-1188

  Saurabh, Kumar ^a   Sharma, Amit ^a   Yadav, Sanjay ^a   Parmar, Devendra ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

Author keywords

Cytochrome P450; Enzyme; Expression; Lymphocytes; Surrogate; Tissue

Indexed keywords

3 METHYLCHOLANTHRENE; ACETONE; ALPHA NAPHTHOFLAVONE; AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; DIMETHYL SULFOXIDE; ETHOXYRESORUFIN; FURAFYLLINE; HYPOXIA INDUCIBLE FACTOR 1BETA; LIVER ENZYME; MESSENGER RNA; POLYCYCLIC AROMATIC HYDROCARBON; PROADIFEN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DEALKYLATION; ENVIRONMENTAL EXPOSURE; ENZYME METABOLISM; GENE EXPRESSION PROFILING; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE; MALE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; BLOTTING, WESTERN; CYTOCHROME P-450 CYP1A1; CYTOCHROMES; LYMPHOCYTES; MALE; POLYCYCLIC HYDROCARBONS, AROMATIC; RATS; RATS, WISTAR; RECEPTORS, ARYL HYDROCARBON; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 77249097285     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2009.11.021     Document Type: Article

References (49)

1. Guengerich F.P. Metabolic activation of carcinogens. Pharmacol Ther 1992, 54:17-61.
2. Bartsch H., Nair U., Risch A., Rojas M., Wikman H., Alexandrov K. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev 2000, 9:3-28.
3. Nebert D.W. Role of genetics and drug metabolism in human cancer risk. Mutat Res 1991, 247:267-281.
4. Whitlock J.P. Induction of cytochrome P4501A1. Annu Rev Pharmacol Toxicol 1999, 39:103-125.
5. Fujii-Kuriyama Y., Mimura J. Molecular mechanisms of AhR functions in the regulation of cytochrome P450 genes. Biochem Biophys Res Commun 2005, 338:311-317.
6. Kellermann G., Luyten-Kellermann M., Shaw C.R. Genetic variation of aryl hydrocarbon hydroxylase in human lymphocytes. Am J Hum Genet 1973, 25:327-331.
7. Hayashi S., Watanabe J., Nakachi K., Eguchi H., Gotoh O., Kawajiri K. Interindividual difference in expression of human Ah receptor and related P450 genes. Carcinogenesis 1994, 15:801-806.
8. Schmidt J.V., Bradfield C.A. Ah receptor signaling pathways. Annu Rev Cell Dev Biol 1996, 12:55-89.
9. Smart J., Daly A.K. Variation in induced CYP1A1 levels: relationship to CYP1A1, Ah receptor and GSTM1 polymorphisms. Pharmacogenetics 2000, 10:11-24.
10. Nebert D.W. The Ah locus: genetic differences in toxicity, cancer, mutation, and birth defects. Crit Rev Toxicol 1989, 20:153-174.
11. Fung J., Thomas P.E., Iba M.M. Cytochrome P450 1A1 in rat peripheral blood lymphocytes: inducibility in vivo and bioactivation of benzo[a]pyrene in the Salmonella typhimurium mutagenicity assay in vitro. Mutat Res 1999, 438:1-12.
12. Dey A., Parmar D., Dayal M., Dhawan A., Seth P.K. Cytochrome P450 1A1 (CYP1A1) in blood lymphocytes evidence for catalytic activity and mRNA expression. Life Sci 2001, 69:383-393.
13. Furukawa M., Nishimura M., Ogino D., Chiba R., Ikai I., Ueda N., et al. Cytochrome p450 gene expression levels in peripheral blood mononuclear cells in comparison with the liver. Cancer Sci 2004, 95:520-529.
14. Jacquet M., Lambert V., Todaro A., Kremers P. Mitogen-activated lymphocytes: a good model for characterising lung CYP1A1 inducibility. Eur J Epidemiol 1997, 13:177-183.
15. Whitlock J.P., Cooper H.L., Gelboin V.H. Aryl hydrocarbon (benzopyrene) hydroxylase is stimulated in human lymphocytes by mitogens and benz(a)anthracene. Science 1972, 177:618-619.
16. Baum A., Gatchel R.J., Krantz D.S. An Introduction To Health Psychology 1997, McGraw-Hill, New York. 3rd ed.
17. Kouri R.E., Imblum R.L., Sosnowski R.G., Slomiany D.J., McKinney C.E. Parameters influencing quantitation of 3-methylcholanthrene-induced aryl hydrocarbon hydroxylase activity in cultured human lymphocytes. J Environ Pathol Toxicol 1979, 2:1079-1098.
18. Siest G., Jeannesson E., Marteau J.B., Samara A., Marie B., Pfister M., et al. Transcription factor and drug-metabolizing enzyme gene expression in lymphocytes from healthy human subjects. Drug Metab Dispos 2008, 36:182-189.
19. Johri A., Dhawan A., Lakhan Singh R., Parmar D. Effect of prenatal exposure of deltamethrin on the ontogeny of xenobiotic metabolizing cytochrome P450s in the brain and liver of offsprings. Toxicol Appl Pharmacol 2006, 214:279-289.
20. Huang P., Rannug A., Ahlbom E., Håkansson H., Ceccatelli S. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the expression of cytochrome P450 1A1, the aryl hydrocarbon receptor, and the aryl hydrocarbon receptor nuclear translocator in rat brain and pituitary. Toxicol Appl Pharmacol 2000, 169:159-167.
21. Schilter B., Omiecinski C.J. Regional distribution and expression modulation of cytochrome P-450 and epoxide hydrolase mRNAs in the rat brain. Mol Pharmacol 1993, 44:990-996.
22. Piscaglia F., Knittel T., Kobold D., Barnikol-Watanabe S., Di Rocco P., Ramadori G. Cellular localization of hepatic cytochrome 1B1 expression and its regulation by aromatic hydrocarbons and inflammatory cytokines. Biochem Pharmacol 1999, 58:157-165.
23. Timsit Y.E., Chia F.S., Bhathena A., Riddick D.S. Aromatic hydrocarbon receptor expression and function in liver of hypophysectomized male rats. Toxicol Appl Pharmacol 2002, 185:136-145.
24. Pustylnyak V.O., Gulyaeva L.F., Lyakhovich V.V. CAR expression and inducibility of CYP2B genes in liver of rats treated with PB-like inducers. Toxicology 2005, 216:147-153.
25. Shah P.P., Saurabh K., Pant M.C., Mathur N., Parmar D. Evidence for increased cytochrome P450 1A1 expression in blood lymphocytes of lung cancer patients. Mutat Res 2009, 670:74-78.
26. Baldwin S.J., Bramhall J.L., Ashby C.A., Yue L., Murdock P.R., Hood S.R., et al. Cytochrome P450 gene induction in rats ex vivo assessed by quantitative real-time reverse transcriptase-polymerase chain reaction (TaqMan). Drug Metab Dispos 2006, 34:1063-1069.
27. Vondrácek J., Svihálková-Sindlerová L., Pencíková K., Krcmár P., Andrysík Z., Chramostová K., et al. 7H-Dibenzo[c,g]carbazole and 5,9-dimethyldibenzo[c,g]carbazole exert multiple toxic events contributing to tumor promotion in rat liver epithelial 'stem-like' cells. Mutat Res 2006, 596:43-56.
28. Shirota M., Mukai M., Sakurada Y., Doyama A., Inoue K., Haishima A., et al. Effects of vertically transferred 3,3′,4,4′,5-pentachlorobiphenyl (PCB-126) on the reproductive development of female rats. J Reprod Dev 2006, 52:751-761.
29. Qin G., Meng Z. The expressions of protooncogenes and CYP1A in lungs of rats exposed to sulfur dioxide and benzo(a)pyrene. Regul Toxicol Pharmacol 2006, 45:36-43.
30. Parmar D., Dhawan A., Dayal M., Seth P.K. Immunochemical and biochemical evidence for expression of Phenobarbital and 3-methylcholanthrene-inducible isoenzymes of cytochrome P450 in rat brain. Int J Toxicol 1998, 17:619-630.
31. Hannon-Fletcher M.P., Barnett Y.A. Lymphocyte cytochrome P450 expression: inducibility studies in male Wistar rats. Br J Biomed Sci 2008, 65:1-6.
32. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193:265-275.
33. Baron J.M., Zwadlo-Klarwasser G., Jugert F., Hamann W., Rübben A., Mukhtar H., et al. Cytochrome P450 1B1: a major P450 isoenzyme in human blood monocytes and macrophage subsets. Biochem Pharmacol 1998, 56:1105-1110.
34. Spencer D.L., Masten S.A., Lanier K.M., Yang X., Grassman J.A., Miller C.R., et al. Quantitative analysis of constitutive and 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced cytochrome P450 1B1 expression in human lymphocytes. Cancer Epidemiol Biomarkers Prev 1999, 8:139-146.
35. Vanden Heuvel J.P., Clark G.C., Thompson C.L., McCoy Z., Miller C.R., Lucier G.W., et al. CYP1A1 mRNA levels as a human exposure biomarker: use of quantitative polymerase chain reaction to measure CYP1A1 expression in human peripheral blood lymphocytes. Carcinogenesis 1993, 14:2003-2006.
36. Dey A., Dhawan A., Kishore Seth P., Parmar D. Evidence for cytochrome P450 2E1 catalytic activity and expression in rat blood lymphocytes. Life Sci 2005, 77:1082-1093.
37. Dey A., Yadav S., Dhawan A., Seth P.K., Parmar D. Evidence for cytochrome P450 3A expression and catalytic activity in rat blood lymphocytes. Life Sci 2006, 79:1729-1735.
38. Cosma G.N., Toniolo P., Currie D., Pasternack B.S., Garte S.J. Expression of the CYP1A1 gene in peripheral lymphocytes as a marker of exposure to creosote in railroad workers. Cancer Epidemiol Biomarkers Prev 1992, 1:137-142.
39. Finnström N., Thörn M., Lööf L., Rane A. Independent patterns of cytochrome P450 gene expression in liver and blood in patients with suspected liver disease. Eur J Clin Pharmacol 2001, 57:403-409.
40. Haas C.E., Brazeau D., Cloen D., Booker B.M., Frerichs V., Zaranek C., et al. Cytochrome P450 mRNA expression in peripheral blood lymphocytes as a predictor of enzyme induction. Eur J Clin Pharmacol 2005, 61:583-593.
41. Lin P., Hu S.W., Chang T.H. Correlation between gene expression of aryl hydrocarbon receptor (AhR), hydrocarbon receptor nuclear translocator (Arnt), cytochromes P4501A1 (CYP1A1) and 1B1 (CYP1B1), and inducibility of CYP1A1 and CYP1B1 in human lymphocytes. Toxicol Sci 2003, 71:20-26.
42. Nohara K., Ao K., Miyamoto Y., Ito T., Suzuki T., Toyoshiba H., et al. Comparison of the 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced CYP1A1 gene expression profile in lymphocytes from mice, rats, and humans: most potent induction in humans. Toxicology 2006, 225:204-213.
43. Spatzenegger M., Horsmans Y., Verbeeck R.K. CYP1A1 but not CYP1A2 proteins are expressed in human lymphocytes. Pharmacol Toxicol 2000, 86:242-244.
44. Murray G.I., Taylor M.C., McFadyen M.C., McKay J.A., Greenlee W.F., Burke M.D., et al. Tumor-specific expression of cytochrome P450 CYP1B1. Cancer Res 1997, 57:3026-3031.
45. McFadyen M.C., Breeman S., Payne S., Stirk C., Miller I.D., Melvin W.T., et al. Immunohistochemical localization of cytochrome P450 CYP1B1 in breast cancer with monoclonal antibodies specific for CYP1B1. J Histochem Cytochem 1999, 47:1457-1464.
46. Shimada T., Hayes C.L., Yamazaki H., Amin S., Hecht S.S., Guengerich F.P., et al. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res 1996, 56:2979-2984.
47. Tsuchiya Y., Nakajima M., Takagi S., Taniya T., Yokoi T. MicroRNA regulates the expression of human cytochrome P450 1B1. Cancer Res 2006, 66:9090-9098.
48. Stadler J., Trockfeld J., Schmalix W.A., Brill T., Siewert J.R., Greim H., et al. Inhibition of cytochromes P4501A by nitric oxide. Proc Natl Acad Sci USA 1994, 91:3559-3563.
49. Murray G.I., Melvin W.T., Greenlee W.F., Burke M.D. Regulation, function, and tissue-specific expression of cytochrome P450 CYP1B1. Annu Rev Pharmacol Toxicol 2001, 41:297-316.